2HB Stock Overview
A venture capital firm. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Carlson Investments SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.81 |
| 52 Week High | zł2.69 |
| 52 Week Low | zł0.81 |
| Beta | 1.76 |
| 11 Month Change | -40.58% |
| 3 Month Change | -15.30% |
| 1 Year Change | -54.65% |
| 33 Year Change | -91.90% |
| 5 Year Change | n/a |
| Change since IPO | -90.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2HB | DE Capital Markets | DE Market | |
|---|---|---|---|
| 7D | -49.1% | 0.5% | -0.2% |
| 1Y | -54.7% | 26.6% | 7.8% |
Return vs Industry: 2HB underperformed the German Capital Markets industry which returned 28.2% over the past year.
Return vs Market: 2HB underperformed the German Market which returned 7.9% over the past year.
Price Volatility
| 2HB volatility | |
|---|---|
| 2HB Average Weekly Movement | 28.4% |
| Capital Markets Industry Average Movement | 4.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2HB's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 2HB's weekly volatility has decreased from 35% to 28% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | n/a | www.carlsonvc.com/en |
Carlson Investments SE is a venture capital firm. The firm prefer to make investments in financial, medical, and deep technology industries. The firm seeks to make investments in Europe, North America and Asia, with a particular focus on Central and Eastern Europe.
Carlson Investments SE Fundamentals Summary
| 2HB fundamental statistics | |
|---|---|
| Market cap | €8.16m |
| Earnings (TTM) | -€1.40m |
| Revenue (TTM) | €1.11m |
7.3x
P/S Ratio-5.8x
P/E RatioIs 2HB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2HB income statement (TTM) | |
|---|---|
| Revenue | zł4.82m |
| Cost of Revenue | zł569.78k |
| Gross Profit | zł4.25m |
| Other Expenses | zł10.30m |
| Earnings | -zł6.05m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.66 |
| Gross Margin | 88.18% |
| Net Profit Margin | -125.53% |
| Debt/Equity Ratio | 6.6% |
How did 2HB perform over the long term?
See historical performance and comparison